Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioRestorative Therapies, Inc.BRTX · Entity 8277 | Director | August 29, 2019 | September 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioRestorative Therapies, Inc.
Report date August 29, 2019 · Filed September 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,850 |
Reported balance
After 2019-08-29 transaction · row 1
1 source rowRow 1 · 2019-08-29 · Purchase · Acquired 17,850 · Balance 123,850 |
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2024-06-27 | Direct | 15,000 |
Reported balance
Holding disclosure · report date 2019-08-29 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 15,000 F1: The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016. |
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2024-10-23 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2019-08-29 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 25,000 F2: The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017. |
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2025-09-04 | Direct | 60,000 |
Reported balance
Holding disclosure · report date 2019-08-29 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 60,000 F3: The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. |
| OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2026-06-10 | Direct | 64,000 |
Reported balance
Holding disclosure · report date 2019-08-29 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 64,000 F4: The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $4.00 · Expires 2022-03-01 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2019-08-29 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 30,000 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2027-06-23 | Direct | 125,000 |
Reported balance
Holding disclosure · report date 2019-08-29 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 125,000 F5: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2028-10-29 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2019-08-29 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 75,000 F6: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016.
F2: The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017.
F3: The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
F4: The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018.
F5: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019.
F6: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2019 Filed Sep 3, 2019 16:25 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 17,850 | $0.28 | $4,917.68 |
DisclosureSEC source: 0001567619-19-017784 · doc1.xml · nonDerivative · entry 1 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,850 Read SEC document |
| August 28, 2019 Filed Aug 29, 2019 16:23 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 35,000 | $0.27 | $9,450.00 |
DisclosureSEC source: 0001567619-19-017679 · doc1.xml · nonDerivative · entry 2 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,000 Read SEC document |
| August 27, 2019 Filed Aug 29, 2019 16:23 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 35,000 | $0.28 | $9,730.00 |
DisclosureSEC source: 0001567619-19-017679 · doc1.xml · nonDerivative · entry 1 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,000 Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 75,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 16 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 75,000 | Not disclosed Strike: $1.23 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 15 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 125,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 14 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-06-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 125,000 | Not disclosed Strike: $3.35 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 13 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2027-06-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantOption · Derivative | 64,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 11 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,000 Underlying: Common Stock · 64,000 shares Expires 2026-06-10 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerOption · Derivative | 64,000 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 10 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,000 shares Expires 2026-06-10 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 21,334 shares on June 10, 2016, and 21,333 shares on each of June 10, 2017 and June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantOption · Derivative | 60,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 9 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2025-09-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerOption · Derivative | 60,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 8 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2025-09-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantOption · Derivative | 25,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 7 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-10-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerOption · Derivative | 25,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 6 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-10-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantOption · Derivative | 15,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 3 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2024-06-27 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 19:39 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerOption · Derivative | 15,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007603 · doc1.xml · derivative · entry 2 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2024-06-27 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016. Read SEC document |
| October 29, 2018 Filed Oct 30, 2018 16:26 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 75,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004780 · doc1.xml · derivative · entry 10 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F7 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| June 23, 2017 Filed Jun 26, 2017 16:53 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 125,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001140361-17-026100 · doc1.xml · derivative · entry 9 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-06-23 F6 · derivative.exercise_date: The option is exercisable to the extent of 41,667 shares on June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 17:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantWarrant · Derivative | 30,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001140361-17-010338 · doc1.xml · derivative · entry 8 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2022-03-01 F1 · price: In exchange for accrued director fees. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 17:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantCommon Stock | 30,000 | $3.00 | $90,000.00 |
DisclosureSEC source: 0001140361-17-010338 · doc1.xml · nonDerivative · entry 1 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 F1 · price: In exchange for accrued director fees. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:44 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantOption · Derivative | 60,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007729 · doc1.xml · derivative · entry 9 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2025-09-04 F6 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:44 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerOption · Derivative | 60,000 | Not disclosed Strike: $7.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007729 · doc1.xml · derivative · entry 8 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2025-09-04 F6 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 30,000 shares on December 22, 2015 and 10,000 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:44 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantOption · Derivative | 25,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007729 · doc1.xml · derivative · entry 7 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-10-23 F6 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:44 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerOption · Derivative | 25,000 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-007729 · doc1.xml · derivative · entry 6 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-10-23 F6 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on October 23, 2015 and 8,333 shares on each of October 23, 2016 and October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:44 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantOption · Derivative | 15,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007729 · doc1.xml · derivative · entry 3 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2024-06-27 F6 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:44 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerOption · Derivative | 15,000 | Not disclosed Strike: $5.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007729 · doc1.xml · derivative · entry 2 Tonna Paul Jude · CIK 0001612143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2024-06-27 F6 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option vests to the extent of 5,000 shares on each of June 27, 2014, June 27, 2015 and June 27, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.